Back
to sessions
Sep 28
Quick Pitch
MODERATOR(S)
Joseph Miccio, MD - Penn State Hershey Medical Center
Nitin Ohri, MD, MS - Albert Einstein College of Medicine
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
05:00pm - 05:05pm ETSpeaker: Joseph Miccio, MD - Penn State Hershey Medical Center, Hershey
-
05:05pm - 05:10pm ET
Phase III Trial to Compare Weekly and Triweekly Usage of Docetaxel and Cisplatin in Concurrent Chemoradiotherapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
Speaker: Dan Yang, MD - Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, P.R. China, Beijing -
05:10pm - 05:15pm ET
Coronary Artery Calcifications and Major Adverse Cardiac Events after Radiation Therapy for Locally-Advanced Non-Small Cell Lung Cancer
Speaker: Christopher Kelsey, MD, FASTRO - Duke University Medical Center, Durham -
05:15pm - 05:20pm ETSpeaker: Judi van Diessen, MD, PhD - NKI-AvL, Amsterdam
-
05:20pm - 05:25pm ET
Risk Classifier for Treatment of Stage III Non-Small Cell Lung Cancer Using Competing Event Regression: Ancillary Analysis of RTOG 0617
Speaker: Ryan Morse, MD - University of Kansas Medical Center, Kansas City -
05:25pm - 05:30pm ET
Predictors of Failure to Undergo Planned Resection after Neoadjuvant Chemoimmunotherapy for LA-NSCLC
Speaker: Julian McDonald, BA - Perelman School of Medicine at the University of Pennsylvania, Philadelphia -
05:30pm - 05:35pm ET
Peripheral PD-1?CD8? T-cell TCR Dynamics during Radiotherapy Predict Survival in Unresectable Locally Advanced Non-Small Cell Lung Cancer
Speaker: Ying Jiang, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing -
05:35pm - 05:55pm ETSpeaker: Nitin Ohri, MD, MS - Albert Einstein College of Medicine, Bronx
-
05:55pm - 06:00pm ETSpeaker: Joseph Miccio, MD - Penn State Hershey Medical Center, Hershey